Get startedLog in
    Picture of Sun Pharma Advanced Research Co logo

    SPARC — Sun Pharma Advanced Research Co Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Sun Pharma Advanced Research Co, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue2,5301,3722,388755718
    Cost of Revenue
    Gross Profit2,1631,0652,045350368
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Other Operating Expenses
    Total Operating Expenses3,9873,3334,6244,8704,058
    Operating Profit-1,457-1,961-2,236-4,115-3,341
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-1,511-2,034-2,226-3,868-3,428
    Provision for Income Taxes
    Net Income After Taxes-1,511-2,034-2,226-3,872-3,425
    Net Income Before Extraordinary Items
    Net Income-1,511-2,034-2,226-3,872-3,425
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-1,511-2,034-2,226-3,872-3,425
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-5.78-7.92-7.81-11.9-10.6